Biomarin Pharmaceutical (BMRN) Asset Utilization Ratio (2010 - 2026)
Biomarin Pharmaceutical's Asset Utilization Ratio came in at 0.34 for Q2 2026, down 20.1% from 0.42 a year earlier and down 16.3% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
For FY2025, Biomarin Pharmaceutical's Asset Utilization Ratio was 0.44, up 7.0% from FY2024.
- Asset Utilization Ratio has increased in each of the last four years.
- Going back by year, Asset Utilization Ratio was 0.41 in FY2024 (+12.7%), 0.37 in FY2023 (+8.1%), 0.34 in FY2022 (+8.7%) and 0.31 in FY2021 (-11.8%).
- The Q2 2026 figure represents the lowest quarterly Asset Utilization Ratio since Q4 2022.
- Year-over-year, Asset Utilization Ratio increased in six of the last eight quarters, with growth averaging 5.1%.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q4 2024 (growth of 15.9%), and the weakest in Q2 2026 (a decline of 20.1%).
- Business Quant data shows BMRN's Asset Utilization Ratio at 0.40 (Q1 2026), 0.42 (Q4 2025) and 0.41 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 0.47 |
| 10 | Biomarin Pharmaceutical | 11.59 Bn | 5.45 Bn | 786.91 Mn | 0.34 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.34 |
| Mar 31, 2026 | 0.40 |
| Dec 31, 2025 | 0.42 |
| Sep 30, 2025 | 0.41 |
| Jun 30, 2025 | 0.42 |
| Mar 31, 2025 | 0.42 |
| Dec 31, 2024 | 0.41 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | 0.37 |
| Mar 31, 2024 | 0.36 |
| Dec 31, 2023 | 0.36 |
| Sep 30, 2023 | 0.35 |
| Jun 30, 2023 | 0.34 |
| Mar 31, 2023 | 0.34 |
| Dec 31, 2022 | 0.33 |
| Sep 30, 2022 | 0.32 |
| Jun 30, 2022 | 0.31 |
| Mar 31, 2022 | 0.31 |
| Dec 31, 2021 | 0.31 |
| Sep 30, 2021 | 0.31 |
API Access
Biomarin Pharmaceutical Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();